First-line treatment of EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis

Abstract This systematic review and network meta-analysis evaluates first-line treatment options for patients with EGFR-mutant non-small cell lung cancer (NSCLC) and brain metastases. We analyzed 24 randomized controlled trials (RCTs) involving 2,682 patients, comparing various EGFR tyrosine kinase...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jietao Ma, Xiaoxue Pang, Shuling Zhang, Letian Huang, Li Sun, Chengbo Han
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-10-01
coleção:	Scientific Reports
Assuntos:	EGFR-TKIs Non-small cell lung cancer Brain metastases First-line therapy Overall survival
Acesso em linha:	https://doi.org/10.1038/s41598-024-74496-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!